| MolName | (E)-3-(furan-2-yl)-N-[[4-[[6-[[2-[[4-[[(E)-3-(furan-2-yl)prop-2-enoyl]carbamothioylamino]phenyl]sulfonylamino]-1,3-benzothiazol-6-yl]oxy]-1,3-benzothiazol-2-yl]sulfamoyl]phenyl]carbamothioyl]prop-2-enamide |
| MolecularFormula | C42H30N8O9S6 |
| Smiles | O=C(/C=C/c1ccco1)NC(Nc(cc1)ccc1S(Nc1nc(ccc(Oc(cc2)cc3c2nc(NS(c(cc2)ccc2NC(NC(/C=C/c2ccco2)=O)=S)(=O)=O)s3)c2)c2s1)(=O)=O)=S |
| InChI | InChI=1S/C42H30N8O9S6/c51-37(19-11-27-3-1-21-57-27)47-39(60)43-25-5-13-31(14-6-25)64(53,54)49-41-45-33-17-9-29(23-35(33)62-41)59-30-10-18-34-36(24-30)63-42(46-34)50-65(55,56)32-15-7-26(8-16-32)44-40(61)48-38(52)20-12-28-4-2-22-58-28/h1-24H,(H,45,49)(H,46, |
| InChIK | FYCPHHZNSNDACR-UHFFFAOYSA-N |
| TotalMolweight | 983.143 |
| Molweight | 983.143 |
| MonoisotopicMass | 982.045997 |
| CLogP | 6.9538 |
| CLogS | -12.731 |
| H Acceptors | 17 |
| H Donors | 6 |
| TotalSurfaceArea | 699.88 |
| Relative PSA | 0.44133 |
| PolarSurfaceArea | 373.31 |
| Druglikeness | 3.1262 |
| Mutagenic | high |
| Tumorigenic | none |
| Reproductive Effective | high |
| Irritant | none |
| Nasty Functions | thio-amide/urea |
| Shape Index | 0.63077 |
| Fragments | 1 |
| Non HAtoms | 65 |
| NonCHAtoms | 23 |
| Electronegative Atoms | 23 |
| Rotatable Bond | 12 |
| Rings Closures | 8 |
| Small Rings | 8 |
| Aromatic Rings | 8 |
| Aromatic Atoms | 40 |
| Sp3Atoms | 5 |
| Symmetricatoms | 35 |
| Amides | 4 |
| Aromatic Nitrogens | 2 |
| StereoCon |
Click to Load Molecule:
1 - (E)-3-(furan-2-yl)-N-[[4-[[6-[[2-[[4-[[(E)-3-(furan-2-yl)prop-2-enoyl]carbamothioylamino]phenyl]sulfonylamino]-1,3-benzothiazol-6-yl]oxy]-1,3-benzothiazol-2-yl]sulfamoyl]phenyl]carbamothioyl]prop-2-enamide | 2 - (E)-3-(furan-2-yl)-N-[[4-[[6-[[2-[[4-[[(E)-3-(furan-2-yl)prop-2-enoyl]carbamothioylamino]phenyl]sulfonylamino]-1,3-benzothiazol-6-yl]oxy]-1,3-benzothiazol-2-yl]sulfamoyl]phenyl]carbamothioyl]prop-2-enamide